Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Diabetes Care ; 45(10): 2247-2254, 2022 10 01.
Article in English | MEDLINE | ID: mdl-35594057

ABSTRACT

OBJECTIVE: To examine trends in diabetic retinopathy (DR) and diabetic macular edema (DME) in adolescents with type 1 diabetes between 1990 and 2019. RESEARCH DESIGN AND METHODS: We analyzed 5,487 complication assessments for 2,404 adolescents (52.7% female, aged 12-20 years, diabetes duration >5 years), stratified by three decades (1990-1999, 2000-2009, 2010-2019). DR and DME were graded according to the modified Airlie House classification from seven-field stereoscopic fundal photography. RESULTS: Over three decades, the prevalence of DR was 40, 21, and 20% (P < 0.001) and DME 1.4, 0.5, and 0.9% (P = 0.13), respectively, for 1990-1999, 2000-2009, and 2010-2019. Continuous subcutaneous insulin infusion (CSII) use increased (0, 12, and 55%; P < 0.001); mean HbA1c was bimodal (8.7, 8.5, and 8.7%; P < 0.001), and the proportion of adolescents meeting target HbA1c <7% did not change significantly (8.3, 7.7, and 7.1%; P = 0.63). In multivariable generalized estimating equation analysis, DR was associated with 1-2 daily injections (odds ratio 1.88, 95% CI 1.42-2.48) and multiple injections in comparison with CSII (1.38, 1.09-1.74); older age (1.11, 1.07-1.15), higher HbA1c (1.19, 1.05-1.15), longer diabetes duration (1.15, 1.12-1.18), overweight/obesity (1.27, 1.08-1.49) and higher diastolic blood pressure SDS (1.11, 1.01-1.21). DME was associated with 1-2 daily injections (3.26, 1.72-6.19), longer diabetes duration (1.26, 1.12-1.41), higher diastolic blood pressure SDS (1.66, 1.22-2.27), higher HbA1c (1.28, 1.03-1.59), and elevated cholesterol (3.78, 1.84-7.76). CONCLUSIONS: One in five adolescents with type 1 diabetes had DR in the last decade. These findings support contemporary guidelines for lower glycemic targets, increasing CSII use, and targeting modifiable risk factors including blood pressure, cholesterol, and overweight/obesity.


Subject(s)
Diabetes Mellitus, Type 1 , Diabetes Mellitus, Type 2 , Diabetic Retinopathy , Macular Edema , Adolescent , Cholesterol , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Female , Glycated Hemoglobin , Humans , Insulin/therapeutic use , Macular Edema/epidemiology , Macular Edema/etiology , Male , Obesity/complications , Overweight/complications , Risk Factors
3.
Pediatr Diabetes ; 21(2): 271-279, 2020 03.
Article in English | MEDLINE | ID: mdl-31800147

ABSTRACT

BACKGROUND: Microbial exposures in utero and early life shape the infant microbiome, which can profoundly impact on health. Compared to the bacterial microbiome, very little is known about the virome. We set out to characterize longitudinal changes in the gut virome of healthy infants born to mothers with or without type 1 diabetes using comprehensive virome capture sequencing. METHODS: Healthy infants were selected from Environmental Determinants of Islet Autoimmunity (ENDIA), a prospective cohort of Australian children with a first-degree relative with type 1 diabetes, followed from pregnancy. Fecal specimens were collected three-monthly in the first year of life. RESULTS: Among 25 infants (44% born to mothers with type 1 diabetes) at least one virus was detected in 65% (65/100) of samples and 96% (24/25) of infants during the first year of life. In total, 26 genera of viruses were identified and >150 viruses were differentially abundant between the gut of infants with a mother with type 1 diabetes vs without. Positivity for any virus was associated with maternal type 1 diabetes and older infant age. Enterovirus was associated with older infant age and maternal smoking. CONCLUSIONS: We demonstrate a distinct gut virome profile in infants of mothers with type 1 diabetes, which may influence health outcomes later in life. Higher prevalence and greater number of viruses observed compared to previous studies suggests significant underrepresentation in existing virome datasets, arising most likely from less sensitive techniques used in data acquisition.


Subject(s)
Diabetes Mellitus, Type 1 , Gastrointestinal Microbiome , Infant, Newborn , Pregnancy in Diabetics , Virome , Case-Control Studies , Feces/virology , Female , Humans , Male , Pregnancy
4.
Open Forum Infect Dis ; 6(2): ofz025, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30815502

ABSTRACT

BACKGROUND: The importance of gut bacteria in human physiology, immune regulation, and disease pathogenesis is well established. In contrast, the composition and dynamics of the gut virome are largely unknown; particularly lacking are studies in pregnancy. We used comprehensive virome capture sequencing to characterize the gut virome of pregnant women with and without type 1 diabetes (T1D), longitudinally followed in the Environmental Determinants of Islet Autoimmunity study. METHODS: In total, 61 pregnant women (35 with T1D and 26 without) from Australia were examined. Nucleic acid was extracted from serial fecal specimens obtained at prenatal visits, and viral genomes were sequenced by virome capture enrichment. The frequency, richness, and abundance of viruses were compared between women with and without T1D. RESULTS: Two viruses were more prevalent in pregnant women with T1D: picobirnaviruses (odds ratio [OR], 4.2; 95% confidence interval [CI], 1.0-17.1; P = .046) and tobamoviruses (OR, 3.2; 95% CI, 1.1-9.3; P = .037). The abundance of 77 viruses significantly differed between the 2 maternal groups (≥2-fold difference; P < .02), including 8 Enterovirus B types present at a higher abundance in women with T1D. CONCLUSIONS: These findings provide novel insight into the composition of the gut virome during pregnancy and demonstrate a distinct profile of viruses in women with T1D.

5.
Rev Med Virol ; 28(3): e1974, 2018 05.
Article in English | MEDLINE | ID: mdl-29569297

ABSTRACT

Virus infections are implicated in the development of type 1 diabetes based on epidemiological, clinical, in vitro cell-based and molecular studies, and animal models. We reviewed the association between virus infections in pregnant women and development of islet autoimmunity or type 1 diabetes in their offspring. We performed a systematic review and meta-analysis, analysed using random effects models, of human studies from Medline and EMBASE without language restriction. Inclusion criteria were as follows: cohort and case-control studies measuring viral nucleic acid in blood, stool, urine, or tissue, or serological tests for viruses, in pregnant women whose offspring developed islet autoimmunity and/or type 1 diabetes. All studies required sufficient data to calculate odds ratios and 95% confidence intervals. The 10 studies (4 case control, 6 nested-case control) that met the eligibility criteria included 2992 participants (953 offspring, 2039 mothers), with varying study design. The 2 outcomes examined were islet autoimmunity (n = 466) and type 1 diabetes (n = 2526). Meta-analysis showed a significant association between virus infection during pregnancy and clinical type 1 diabetes during childhood (odds ratio 2·16, 95% CI 1·22-3·80; P = 0·008; heterogeneity X2  = 1·65, I2  = 40%), but no association with islet autoimmunity (1·45, 0·63-3·31; P = 0·38; X2  = 1·34, I2  = 25%). The increased risk of type 1 diabetes following maternal virus infection is consistent with viraemia involving the fetus during pregnancy and suggests a potential causative link between antenatal infection and type 1 diabetes. Larger prospective birth studies with more frequent sampling, and pathogenesis studies, are required to more clearly establish an aetiological link.


Subject(s)
Diabetes Mellitus, Type 1/complications , Pregnancy Complications, Infectious , Pregnancy in Diabetics , Prenatal Exposure Delayed Effects , Virus Diseases/complications , Adult , Autoimmunity , Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 1/immunology , Female , Humans , Odds Ratio , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy in Diabetics/epidemiology , Virus Diseases/epidemiology , Virus Diseases/virology
6.
Yan Ke Xue Bao ; 20(1): 1-5, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15124524

ABSTRACT

PURPOSE: Corneal thickness assessment is a common clinical procedure applied in corneal and contact lens care. This study aims to investigate the effect of age on hypoxia-induced corneal swelling. METHODS: Eighteen male subjects were equally divided into the younger [(23.7 +/- 0.8) years old] and older [(74.4 +/- 2.5) years old] groups. Each subject wore a thick soft contact lens (uniform thickness of 0.3 mm) on the left cornea. With the contact lens in place, the baseline central corneal thickness was measured using a specially designed photo-pachometer. The lens was then patched behind the closed eyelids, producing an extremely hypoxic stress to the cornea. The change in central corneal thickness was monitored every 20 minutes with momentary disruptions to the hypoxic stress over the next 2 hours. The increase in thickness was taken as an index of corneal edema. The rate of change in corneal thickness, as derived from a non-linear mathematical model, was compared between groups. RESULTS: The corneal thickness of both age groups increased significantly with time (P < 0.0001). The mean corneal swelling constant for the older subjects was 16.5 x 10(-3) (S.E.M. = 2.65 x 10(-3)) and the value for the younger subjects was 46.5 x 10(-3) (S.E.M. = 3.25 x 10(-3)). The difference was statistically significant (P < 0.0001). CONCLUSION: Aging cornea has a slower hypoxia-induced edema response compared with the younger group. Whether it is caused by a decreased corneal lactate production or an increased resistance to physical expansion deserves further investigation.


Subject(s)
Cornea/pathology , Corneal Edema/diagnosis , Hypoxia/complications , Adult , Aged , Contact Lenses, Hydrophilic , Corneal Edema/etiology , Female , Humans , Male , Models, Theoretical
7.
Radiol Manage ; 22(1): 37-40, 2000.
Article in English | MEDLINE | ID: mdl-10787760

ABSTRACT

Positron emission tomography (PET), invented over 25 years ago, is the only imaging technique that provides images of the biological basis of disease. Since disease is a biological process, PET routinely detects disease when other imaging studies, such as CT and MRI, are normal. In addition to its clinical effectiveness, PET has been shown to reduce costs, primarily due to the elimination of other less accurate diagnostic tests and ineffective surgeries. PET has been determined to be applicable to a number of specific applications in the areas of: imaging cancer patients, characterizing myocardial blood flow and viability, and brain imaging in various physiological and pathologic conditions. Tremendous progress has been made in resolving the regulatory and reimbursement issues facing the field of PET. Working with HCFA, representatives of the Institute for Clinical PET and the Society of Nuclear Medicine have brought about expanded HCFA coverage for PET. When HCFA first authorized payment for PET, all coverage decisions were restricted to HCFA and an expanded national coverage policy. HCFA revised its national coverage policy in 1997; this was the first of several steps taken by HCFA towards careful expansion of PET reimbursement. In March 1999, three new indications for whole-body PET scans were added to Medicare's coverage policy. The Institute for Clinical PET is continuing to work with HCFA on continued, appropriate expansion of the coverage policy. This article is partially excerpted from a written statement made by Terry Douglass, Ph.D., president of CTI, Inc., on May 12, 1999, before the Senate Committee on Commerce, Science and Transportation and its Subcommittee on Science, Technology and Space. This was part of the committee's study of "Emerging Technologies in the New Millennium."


Subject(s)
Tomography, Emission-Computed , Breast Neoplasms/diagnostic imaging , Centers for Medicare and Medicaid Services, U.S. , Colorectal Neoplasms/diagnostic imaging , Coronary Disease/diagnostic imaging , Coronary Disease/surgery , Cost-Benefit Analysis , Costs and Cost Analysis , Diagnosis, Differential , Evaluation Studies as Topic , Female , Head and Neck Neoplasms/diagnostic imaging , Humans , Insurance, Health, Reimbursement , Lung Neoplasms/diagnosis , Lung Neoplasms/diagnostic imaging , Magnetic Resonance Imaging , Male , Medicare , Tomography, Emission-Computed/economics , Tomography, X-Ray Computed , United States
8.
IEEE Trans Med Imaging ; 14(2): 266-70, 1995.
Article in English | MEDLINE | ID: mdl-18215830

ABSTRACT

A technique determines the optimal window width for orbiting rod transmission studies in positron emission tomography (PET). Windowing reduces noise in orbiting rod transmission studies. Lines-of-response (LOR) which intersect the rods generate primarily true coincidence events. LOR which pass far from the rods generate random and scatter events. Since the angular position of the orbiting rods is known in real-time, LOR which produce mostly noise are gated off. When optimally determined, the rod window width maximizes the noise equivalent counts (NEC) collected in the transmission study. Transaxial rod projection profiles of trues, randoms, and scatter produce NEC versus window width plots. For the ECAT EXACT line of PET systems and a 20-cm water cylinder, optimal is five LOR wide.

9.
J Nucl Med ; 33(4): 595-604, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1552348

ABSTRACT

The design features of a PET system designed for animal studies are described and its performance evaluated. The system employs a two-dimensional modular detector array consisting of bismuth germanate detector elements that are 3.5 mm (transaxially) by 6.25 mm (axially) by 30 mm (deep). These arrays are optically coupled to a pair of dual-photo-multiplier tubes (PMT). The detector ring is 64 cm in diameter with a field of view (FOV) of 40 cm by 5.4 cm axially, acquiring 15 slices at 3.4 mm spacing. These features include: (1) digitization of PMT signals from each block for improved position and energy discrimination of coincident events and (2) dual-window energy discrimination for simultaneous but separate acquisition of photopeak and scatter data. Intrinsic resolution averages 3.5 mm at the center of the FOV, while reconstructed resolution (ramp filter) ranges from 3.8 mm at the center of the FOV to 4.6 mm at an 8 cm radius. Axial resolution averages 4.4 and 4.9 mm and sensitivity averages 4.2 and 6.1 kcps/microCi/cc for cross planes and enhanced direct planes, respectively. Randoms fraction is high due to reduced interplane shielding, giving a peak true count rate of 103 kcps for a 10 cm cylinder. Scatter as a fraction of trues is 16% for a 10 cm cylinder at a lower energy threshold of 350 keV. All parameters are sensitive to energy threshold. Spatial resolution improves by 11% transaxially and 9% axially, scatter fraction drops to 10%, and overall sensitivity drops by 48% when the threshold value is increased from 350 keV to 450 keV.


Subject(s)
Animals, Laboratory , Tomography, Emission-Computed , Animals , Equipment Design , Research
10.
J Cereb Blood Flow Metab ; 11(2): A17-25, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1997482

ABSTRACT

A three-dimensional brain phantom has been developed to simulate the activity distributions found in human brain studies currently employed in positron emission tomography (PET). The phantom has a single contiguous chamber and utilizes thin layers of lucite to provide apparent relative concentrations of 5, 1, and 0 for gray matter, white matter, and CSF structures, respectively. The phantom and an ideal image set were created from the same set of data. Thus, the user has a basis for comparing measured images with an ideal set that allows a quantitative evaluation of errors in PET studies with an activity distribution similar to that found in patients. The phantom was employed in a study of the effect of deadtime and scatter on accuracy in quantitation on a current PET system. Deadtime correction factors were found to be significant (1.1-2.5) at count rates found in clinical studies. Deadtime correction techniques were found to be accurate to within 5%. Scatter in emission and attenuation correction data consistently caused 5-15% errors in quantitation, whereas correction for scatter in both types of data reduced errors in accuracy to less than 5%.


Subject(s)
Brain/diagnostic imaging , Deoxyglucose/analogs & derivatives , Models, Biological , Models, Structural , Tomography, Emission-Computed/standards , Brain/metabolism , Deoxyglucose/metabolism , Deoxyglucose/pharmacokinetics , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...